“The cost-effectiveness of losartan in type 2 diabetics with nephropathy in Switzerland - an analysis of the RENAAL study”, Swiss Med Wkly, vol. 134, no. 3132, pp. 440–447, Aug. 2004, doi: 10.4414/smw.2004.10492.